Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.

[1]  S. Barni,et al.  Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies , 2016, Annals of surgery.

[2]  Kjersti Flatmark,et al.  MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer. , 2015, The British journal of radiology.

[3]  G. Kemp,et al.  Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. , 2015, British journal of anaesthesia.

[4]  Stanley T. Yu,et al.  MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy , 2014, Expert review of gastroenterology & hepatology.

[5]  M. Gollub,et al.  Multiparametric MRI of Rectal Cancer in the Assessment of Response to Therapy: A Systematic Review , 2014, Diseases of the colon and rectum.

[6]  B. Glimelius.  Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? , 2014, Front. Oncol..

[7]  J. Stoker,et al.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.

[8]  N. Francis,et al.  Timing of Surgery After Long-Course Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review of the Literature , 2013, Diseases of the colon and rectum.

[9]  F. Taylor,et al.  MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience. , 2012, AJR. American journal of roentgenology.

[10]  S. Ricci,et al.  Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer , 2012, Annals of Surgical Oncology.

[11]  Gina Brown,et al.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Tait,et al.  Timing of Surgery Following Preoperative Therapy in Rectal Cancer: The Need for a Prospective Randomized Trial? , 2011, Diseases of the colon and rectum.

[13]  Tae Hyun Kim,et al.  Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. , 2010, International journal of radiation oncology, biology, physics.

[14]  Karin Haustermans,et al.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.

[15]  R. Vera,et al.  Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease‐free survival after preoperative radiochemotherapy for advanced rectal cancer , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[16]  P. Quirke,et al.  Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo‐adjuvant treatment: ‘y’‘u’ and ‘p’ need ‘mr’ and ‘ct’ , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[17]  C. Horng,et al.  Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy? , 2007, Annals of Surgical Oncology.

[18]  A. Norman,et al.  Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. , 2007, Radiology.

[19]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[21]  L. Sobin,et al.  The “y” symbol: An important classification tool for neoadjuvant cancer treatment , 2006, Cancer.

[22]  A. Norman,et al.  Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Willett,et al.  Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Shung-Haur Yang,et al.  How Accurate is Magnetic Resonance Imaging in Restaging Rectal Cancer in Patients Receiving Preoperative Combined Chemoradiotherapy? , 2005, Diseases of the colon and rectum.

[25]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[26]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[27]  A. Chan,et al.  Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[28]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[29]  K. Badizadegan,et al.  Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? , 1999, Diseases of the colon and rectum.

[30]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[31]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[32]  J. Macfarlane,et al.  Mesorectal excision for rectal cancer , 1993, The Lancet.

[33]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[34]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.